Evaluation of pharmacokinetic interactions between bicyclol and co-administered drugs in rat and human liver microsomes in vitro and in rats in vivo

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
Shu YangZhigang Zhao

Abstract

Bicyclol is a new synthetic anti-hepatitic drug and primarily metabolized by CYP3A. The aim of this study was to evaluate the pharmacokinetic interactions between bicyclol and co-administered drugs including metformin, pioglitazone, atorvastatin, fenofibrate, Cyclosporin A (CsA), and tacrolimus in rat and human liver microsomes (RLMs/HLMs) in vitro and in rats in vivo. The depletion rate of bicyclol in RLMs was significantly inhibited by 44.8% and 35.5% after preincubation with pioglitazone and fenofibrate while the metabolite formation rate of bicyclol in HLMs was inhibited by 26.1% and 23.9% after preincubation and coincubation with tacrolimus, and by 20.2% after preincubation with CsA. Conversely, preincubation and coincubation with bicyclol significantly inhibited the depletion rate of pioglitazone in RLMs by 34.1% and 27.1%, respectively, and the formation rate of para- and ortho-hydroxy atorvastatin in RLMs and HLMs by 20.6-36.2%. There were no significant pharmacokinetic interactions between bicyclol and pioglitazone in rats after a single or multiple oral treatment. As the selected inhibitory drug concentrations in vitro were significantly higher than those in clinical settings and the maximum inhibition rate did not ex...Continue Reading

References

May 1, 1996·Clinical Pharmacokinetics·A J Scheen
Mar 27, 1998·Clinical Pharmacokinetics·D B Miller, J D Spence
Jul 13, 2000·European Journal of Drug Metabolism and Pharmacokinetics·P A KellyH W Strobel
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Raman VenkataramananNina Singh
Mar 19, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jasminder SahiMichael W Sinz
Jun 4, 2005·Analytical and Bioanalytical Chemistry·M HermannJ L E Reubsaet
Sep 24, 2005·Basic & Clinical Pharmacology & Toxicology·Lauri I KajosaariJanne T Backman
Feb 28, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yang DaiKenneth E Thummel
Jul 27, 2006·Basic & Clinical Pharmacology & Toxicology·Tiina JaakkolaJanne T Backman
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·Marcella MartignoniRuben de Kanter
Jan 5, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Toshiro NiwaAkira Takagi
Aug 23, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J-E ParkJ-G Shin
Sep 20, 2008·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Wei TanYan Li
Jan 20, 2009·Medicinal Chemistry·Geng Tao Liu
Dec 30, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Rune AmundsenHege Christensen
Jan 1, 2015·European Journal of Drug Metabolism and Pharmacokinetics·Jin-Seok ChoiDong-Hyun Choi
Oct 27, 2016·Biological Chemistry·Janett MüllerStefan Oswald
Oct 7, 2016·Acta Pharmaceutica Sinica. B·Fang XieQing-Yu Zhang

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Rune AmundsenHege Christensen
Yao xue xue bao = Acta pharmaceutica Sinica
Mei-hua Ju, Yan Li
© 2022 Meta ULC. All rights reserved